Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Purple Biotech (PPBT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Purple Biotech ADR's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.503 +0.003    +0.56%
13:48:12 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 103,177
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.490 - 0.538
Purple Biotech ADR 0.503 +0.003 +0.56%

Purple Biotech Company Profile

 
Get an in-depth profile of Purple Biotech, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

20

Equity Type

ADR

Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. Its oncology pipeline includes CM24, a humanized monoclonal antibody that blocks the interactions of carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 2 clinical trial for the treatment of pancreatic ductal adenocarcinoma; NT219, a small molecule that targets and inhibits insulin receptor substrate 1 and 2, and signal transducer and activator of transcription, which is in Phase 1/2 clinical trials for the treatment recurrent and/or metastatic squamous cell carcinoma of the head and neck cancer or colorectal adenocarcinoma; and IM1240, a multi-valent antibody designed to activate anti-tumoral immune response against 5T4-positive tumors, which is in preclinical stage. The company has collaboration agreement with Bristol Myers Squibb Company to evaluate the combination of CM24 with the PD-1 inhibitor nivolumab in addition to chemotherapy. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. The company is headquartered in Rehovot, Israel.

Contact Information

Address 4 Oppenheimer Street Science Park
Rehovot, 7670104
Israel
Phone 972 3 933 3121
Fax 972 3 509 7196

Top Executives

Name Age Since Title
Eric K. Rowinsky 65 2019 Independent Chairman of the Board
Sunil Sharma - 2023 Member of Scientific Advisory Board
Robert E. Gagnon 49 2021 Independent Director
Ori Hershkovitz 48 2021 Independent Director
Steven Maron - 2023 Member of Scientific Advisory Board
Scott Faucett - 2014 Member of Scientific Advisory Board
Sean Welton - 2014 Member of Scientific Advisory Board
Suzana Nahum-Zilberberg 52 2021 Independent Director
Eyal Gottlieb - 2023 Member of Scientific Advisory Board
Yael Margolin 70 2023 Independent Director
Simcha Rock 74 2013 Independent Director
Ido Agmon 47 2016 Independent Director
Isaac Israel 46 2012 Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PPBT Comments

Write your thoughts about Purple Biotech
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Aigars Viksna
Aigars Viksna Nov 22, 2021 12:32PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
THIS S.... goes to Zero, as well
Simon Olesen
SimonO Nov 22, 2021 12:32PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
by all means, sell your shares then. This will be double digits before august, likely in a week.
גרגורי ליובוצקי
גרגורי ליובוצקי Jul 30, 2021 5:18AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Target 25
Michael Schabhüttl
Michael Schabhüttl Apr 14, 2021 4:03AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.globenewswire.com/news-release/2021/04/13/2209092/0/en/Purple-Biotech-Presents-Additional-Mechanism-of-Action-Data-for-NT219-at-American-Association-of-Cancer-Research-2021-Annual-Meeting.html
Mike De Angelo
Mike De Angelo Mar 10, 2021 6:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
when this thing will move up?
גרגורי ליובוצקי
גרגורי ליובוצקי Mar 10, 2021 6:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Its start
גרגורי ליובוצקי
גרגורי ליובוצקי Feb 16, 2021 8:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
price target $25
Feb 10, 2021 5:30PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Morgan Stanley own sonce last week 5%
Shon Cash
Shon Cash Feb 10, 2021 5:30PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Are you from Israel? See you on all my Israel stocks)
Muhammad Kamran
Muhammad Kamran Feb 06, 2021 4:34AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
price target $25
Muhammad Kamran
Muhammad Kamran Feb 06, 2021 4:34AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.investorsobserver.com/symbols/ppbt?_gl=1*1o4a1yg*_ga*dllJazRWZzR0UFJkU0VMZGRlMV9XdGFsdkttZXJEdl8tVDNTOW80T3FPWG51X09qYWI3OW9aSUFUaTEzYmxGeA..
Pronob Mukherjee
Pronob Mukherjee Dec 09, 2020 11:28AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Time to buy KTOV. Stimulus finds & vaccine approval for Pfizer are major catalysts
Muhammad Kamran
Muhammad Kamran Sep 17, 2020 12:54PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://finance.yahoo.com/news/kitov-announces-dosing-first-patient-111000810.html
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email